BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33969124)

  • 21. Central Lymph Node Dissection Improves Lymph Node Clearance in Papillary Thyroid Cancer Patients with Lateral Neck Metastases, Even after Prior Total Thyroidectomy.
    Hall CM; Snyder SK; Lairmore TC
    Am Surg; 2018 Apr; 84(4):531-536. PubMed ID: 29712601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon nanoparticles facilitate lymph nodes dissection and parathyroid glands identification in reoperation of papillary thyroid cancer.
    Su AP; Wang B; Gong YP; Wu WS; Gong RX; Li ZH; Zhu JQ
    Medicine (Baltimore); 2017 Nov; 96(44):e8380. PubMed ID: 29095266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer].
    Bian X; Chen H; Ye X; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):664-8. PubMed ID: 21055244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0].
    Gao Q; Zhao D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1938-40. PubMed ID: 25895310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary Study on the Clinical Significance and Methods of Using Carbon Nanoparticles in Endoscopic Papillary Thyroid Cancer Surgery.
    Rao S; Wang Z; Pan C; Wang Y; Lin Z; Pan Z; Yu J
    Contrast Media Mol Imaging; 2021; 2021():6652315. PubMed ID: 33994886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of Carbon Nanoparticles in Endoscopic Thyroidectomy via Bilateral Areola Approach: Total Thyroidectomy Plus Central Lymph Node Dissection.
    Zhang D; Wang T; Dionigi G; Fu Y; Zhang J; Zhao Y; Li J; Sun H
    J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):1038-1041. PubMed ID: 30939054
    [No Abstract]   [Full Text] [Related]  

  • 27. Application of Carbon Nanoparticle Tracers in the Lateral Neck Lymph Nodes of CN1bx Patients with Papillary Thyroid Carcinoma.
    Qian X; Tang J; Chu Y; Chen L; Chen Z; Li L
    J Nanosci Nanotechnol; 2021 Nov; 21(11):5408-5413. PubMed ID: 33980350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the clinical value of carbon nanoparticles as lymph node tracer in differentiated thyroid carcinoma requiring reoperation.
    Chaojie Z; Shanshan L; Zhigong Z; Jie H; Shuwen X; Peizhi F; Jing X; Xiaowen G; Yang L; Wei Z
    Int J Clin Oncol; 2016 Feb; 21(1):68-74. PubMed ID: 26081253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma.
    Jin S; Bao W; Yang YT; Bai T; Bai Y
    Sci Rep; 2018 Nov; 8(1):17355. PubMed ID: 30478394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
    Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
    Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
    Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of neck dissections in papillary thyroid carcinoma. A modified procedure to reduce parathyroid morbidity.
    Ardito G
    Ann Ital Chir; 2019; 90():185-190. PubMed ID: 31354144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial.
    Zhao J; Wang J; Cheng R; Qin J; Ai Z; Sun H; Guo Z; Zhang X; Zheng X; Gao M
    Front Endocrinol (Lausanne); 2023; 14():1251820. PubMed ID: 38260138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Level IIb neck dissection guided by fine-needle aspiration for N1b papillary thyroid carcinoma.
    Song Y; Xu G; Bai Y; Wang T; Fei K; Zhang B
    Surg Oncol; 2022 Mar; 40():101705. PubMed ID: 35066380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
    Hall CM; LaSeur DC; Snyder SK; Lairmore TC
    Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Level VII is an important component of central neck dissection for papillary thyroid cancer.
    Wang LY; Versnick MA; Gill AJ; Lee JC; Sidhu SB; Sywak MS; Delbridge LW
    Ann Surg Oncol; 2013 Jul; 20(7):2261-5. PubMed ID: 23361896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.